Location History:
- Newtown, PA (US) (2008)
- Plainsboro, NJ (US) (2008 - 2010)
- Tehran, IR (2010)
Company Filing History:
2 out of 2,077 
2 out of 780 
1 out of 76 
Years Active: 2008-2010
Title: Davoud Asgari: Innovator in Kinase Inhibitors
Introduction
Davoud Asgari is a prominent inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 6 patents to his name, Asgari's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, one notable invention is directed to c-fms kinase inhibitors. This invention encompasses compounds of Formula II, which inhibit protein tyrosine kinases, especially c-fms kinase. Another significant patent involves substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors. These compounds are useful for inhibiting tumor growth, treating erectile dysfunction, and addressing other conditions mediated by Rho-kinase, such as coronary heart disease.
Career Highlights
Throughout his career, Davoud Asgari has worked with leading companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Bayer Healthcare LLC. His expertise in the field has allowed him to contribute to innovative solutions that address critical health issues.
Collaborations
Asgari has collaborated with notable professionals in his field, including Mark R Player and Raymond Joseph Patch. These collaborations have further enhanced his research and development efforts.
Conclusion
Davoud Asgari's contributions to the field of kinase inhibitors demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in pharmaceutical research.